Secondary Loss of Response to Dopamine Receptor Agonists in the Treatment of Macroprolactinoma. [PDF]
Alkundi A, Momoh R.
europepmc +1 more source
Pasireotide: A potential therapeutic alternative for resistant prolactinoma.
H. Lasolle +3 more
semanticscholar +1 more source
Cabergoline-induced prolactinoma treatment and subsequent estrogen-driven vascular smooth muscle tumorigenesis in a middle-aged female: A case report. [PDF]
Cintrón-Cartagena K +5 more
europepmc +1 more source
Giant Prolactinoma Resistant to High-Dose Cabergoline in a Young Male Lost to Follow-Up. [PDF]
Das A, Rummun MA, Shams A, Salman A.
europepmc +1 more source
Reframing the Paradigm: A Nuanced Approach to Prolactinoma Management
Jung Hee Kim
openalex +1 more source
Long-term survival in a patient with metastatic prolactinoma: a 12-year follow-up. [PDF]
Hlavinka WJ +4 more
europepmc +1 more source
Autonomic balance and cardiovascular hemodynamic function in men with prolactinoma. [PDF]
Włochacz A +9 more
europepmc +1 more source
Understanding the psychosocial needs of pituitary patients: A survey of Pituitary Foundation members. [PDF]
Forrest, H +3 more
core +2 more sources

